The approval of the law on cannabis in April 2017 marked a significant change for Germany
Before, patients had access to therapies based on dronabinol, a cannabinoid isolated from THC still used by approximately forty thousand patients., However, following the promulgation of this law, prescription of the phytocomplex, that is to say the constituents of the plant, in form of inflorescence or fluid extract, has become possible.
Even though the German market for cannabis is rather new, it already outnumbers Italy in terms of available plant varieties (more than 200 inflorescences), products (around 70 standardized extracts) and companies (with possibly more than 100 operators involved), not to mention in terms of tons of materials consumed every year.